Ranjitkar Manandhar, Nora, et al. “Dasatinib Tyrosine Kinase Inhibitor As Second and Third Line Therapy in Chronic Myeloid Leukemia: Outcome of a Nepalese Study”. Journal of Patan Academy of Health Sciences, vol. 5, no. 1, July 2018, pp. 47-56, https://jpahs.edu.np/index.php/jpahs/article/view/97.